Medicinal Chemistry Support Program for Therapeutic Development

Deadline:04 Jun 2026, 13:00 GMT-4

Tender information

SAM.gov

Bethesda, United States

Type: Presolicitation
Procedure: Presolicitation
Ref. number: e56cee1bad9f478cbad461dcacc890bd
NAICS: 541715

INTRODUCTION PURSUANT TO RFO 5.101 � PRESOLICITATION NOTICE, THIS IS A NOTICE OF A PROPOSED CONTRACT ACTION. THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE MODIFICATION UNDER CONTRACT NO. HHSN271201800001I WITH CURIA …

GLOBAL, INC. The National Institute on Neurological Disorders and Stroke (NINDS) and the NIH Blueprint Neurotherapeutics Network (BPN) at the National Institutes of Health (NIH) intends to modify the Single Award Indefinite Delivery, Indefinite Quantity (IDIQ) Contract No. HHSN271201800001I �Medicin

al Chemistry Support Program for Therapeutic Development� to increase the Single Award IDIQ maximum by $30,145,159 from $39,500,000 to $69,645,159 during the ten (10) year ordering period from March 16, 2018 to March 15, 2028; there are no

Show all tender information

Documents

Show all important dates